Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Standard BioTools Inc. (NASDAQ: LAB), operating within the Healthcare sector, specifically in the Medical Devices industry, is drawing investor attention with its potential for a 28.62% upside based on analyst..
In the ever-evolving world of biotechnology, MBX Biosciences, Inc. (NASDAQ: MBX) stands out with a compelling case for investors seeking high-growth opportunities. With a market capitalization of $721.26 million, this..
Organogenesis Holdings Inc. (NASDAQ: ORGO), a leading player in the regenerative medicine space, is capturing the attention of investors with a tantalizing 94.65% potential upside, according to recent analyst ratings...
Verastem, Inc. (NASDAQ: VSTM), a pioneering biopharmaceutical company, presents a compelling case for investors seeking exposure to the biotechnology sector, particularly in the promising field of cancer treatment. With a..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is increasingly capturing the attention of savvy investors, thanks to its remarkable growth potential and promising advancements in the biotechnology sector. Focused on the development..
LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, particularly in health information services, has captured the attention of investors with its innovative direct-to-patient telehealth model. Based in..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector specializing in medical care facilities, is navigating a challenging financial landscape. With a market capitalization of $492.04 million..
Humacyte, Inc. (NASDAQ: HUMA), a pioneering biotechnology company based in Durham, North Carolina, is making waves in the healthcare sector with its cutting-edge approach to engineering bioengineered human tissues. The..
As the biotechnology sector continues to captivate investors with its promise of groundbreaking treatments, MeiraGTx Holdings plc (NASDAQ: MGTX) stands out for its ambitious pipeline and impressive potential upside. With..
Celcuity Inc. (NASDAQ: CELC), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment and a promising potential upside of..
Opthea Limited (NASDAQ: OPT), an Australian biopharmaceutical company, commands attention within the healthcare sector for its pioneering work in the biotechnology industry. With a market capitalization of $583.1 million, Opthea..
PureTech Health plc (NASDAQ: PRTC), a pioneering entity in the biotechnology space, is drawing significant attention thanks to its impressive potential upside of 176.14% as suggested by analyst target prices...
Autolus Therapeutics plc (NASDAQ: AUTL), a promising player in the biotechnology sector, is captivating investor attention with its substantial growth potential. Despite a modest market cap of $399.21 million and..
Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, is capturing investor attention with an enticing potential upside of 179.01%. Specializing in the cash-pay aesthetic market, Evolus offers..
Prothena Corporation plc (NASDAQ: PRTA) is an intriguing player in the biotechnology sector, focused on tackling the challenging landscape of neurodegenerative diseases and protein dysregulation disorders. Based in Ireland, Prothena..
Abivax SA (ABVX), a French biotechnology company, has emerged as a notable contender in the healthcare sector, attracting investor attention with its promising drug pipeline and considerable growth potential. Headquartered..
Maze Therapeutics, Inc. (NASDAQ: MAZE) emerges as a compelling player in the biotechnology sector, boasting a market capitalization of $1.44 billion. Operating out of South San Francisco, California, Maze is..
ATAI Life Sciences N.V. (NASDAQ: ATAI) stands at the forefront of biotechnology innovation, leveraging cutting-edge research to address pressing mental health challenges. With a compelling market capitalization of $1.48 billion,..
Cogent Biosciences, Inc. (NASDAQ: COGT) is drawing attention in the biotechnology sector with its promising potential upside of 47.12%. As a company dedicated to developing precision therapies for genetically defined..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a burgeoning player in the biotechnology sector, is capturing significant investor attention due to its innovative approach to combating cancer resistance mechanisms. With a market..
